← Eichor
Condition: Pulmonary Hypertension Due To Lung Diseases And Hypoxia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pulmonary Hypertension Due To Lung Diseases And Hypoxia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Giessen Pulmonary Hypertension in Lung Cancer Registry
Phase N/A · 1 location(s) · University of Giessen · NCT04467333
Pulmonary Hypertension Biorepository and Registry
Phase N/A · 1 location(s) · University of Kansas Medical Center · NCT04808596
Ventilator Pressure and Optimization of Compliance and Hemodynamics
NA · 1 location(s) · University of Alabama at Birmingham · NCT06512935
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease
Phase N/A · 67 location(s) · United Therapeutics · NCT06388421
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Phase 2 · 3 location(s) · OrphAI Therapeutics · NCT05798923
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.